Skip to content

Insider · CIK 0001891900

Brendan Teehan

cooofficer

Files at ACAD (ACADIA PHARMACEUTICALS INC). First filing Nov 19, 2024, latest Nov 19, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $174k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ACAD: ACADIA PHARMACEUTICALS INC

ACADOct 9, 2026 · close 19.78

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
16Weak
ACADsell 310b5-1
ACADIA PHARMACEUTICALS INC
$174k
10,329 shares
-14%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 17, 2024ACAD
ACADIA PHARMACEUTICALS INC
MOption exercise
Common Stock
+9,913--62,521Nov 19, 2024
Nov 17, 2024ACAD
ACADIA PHARMACEUTICALS INC
MOption exercise
Common Stock
+9,913--72,434Nov 19, 2024
Nov 19, 2024ACAD
ACADIA PHARMACEUTICALS INC
SOpen-market sale
Common Stock10b5-1
-10,329$16.81$174k62,105Nov 19, 2024
Nov 17, 2024ACAD
ACADIA PHARMACEUTICALS INC
MOption exercise
Restricted Stock Unitsderivative
-9,913$0.00$09,913Nov 19, 2024
Nov 17, 2024ACAD
ACADIA PHARMACEUTICALS INC
MOption exercise
Restricted Stock Unitsderivative
-9,913$0.00$09,913Nov 19, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Brendan Teehan: insider trades and track record | InsiderTell